Physician
Wehbe, Paul
Wehbe, Paul was paid $4.74M by Medicaid between Jan 2018 and Dec 2024, across 64 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoWEHBE, PAUL
PROVIDENCE, RI 02904
PROVIDENCE, RI 02904
33aNPI1083683148assigned 03/14/2006
33bProvider typePediatrics Physician
28Total paid$4.74M
24GClaims101,348
24DCodes billed64
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Rhode Island
Rank by total paid#1 of 265
Median peer was paid$133K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,376 | $500K | |
| 2019 | 4,842 | $184K | |
| 2020 | 11,778 | $488K | |
| 2021 | 18,788 | $779K | |
| 2022 | 16,633 | $806K | |
| 2023 | 19,081 | $1.05M | |
| 2024incomplete | 16,850 | $934K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 20,567 | 17,851 | $1.46M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 6,019 | 5,640 | $603K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.7% | 8,171 | 7,383 | $364K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 6.6% | 8,315 | 7,645 | $313K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.4% | 3,304 | 3,244 | $302K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.9% | 3,201 | 2,869 | $278K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.5% | 2,836 | 2,790 | $262K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.6% | 2,167 | 2,102 | $217K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.2% | 10,601 | 10,264 | $200K |
| 90461 | 2.8% | 3,941 | 3,808 | $134K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.6% | 6,638 | 5,751 | $78K |
| 99050 | 1.5% | 1,877 | 1,796 | $69K |
52 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 560 | $57K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 434 | $42K |
| 82728 | <1% | 511 | $38K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 420 | $36K |
| 86481 | <1% | 196 | $32K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,800 | $30K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,596 | $26K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,060 | $25K |
| 69210 | <1% | 573 | $17K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 752 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 179 | $15K |
| 96127 | <1% | 3,417 | $13K | |
| 99051 | <1% | 510 | $12K | |
| 80061 | Lipid panel | <1% | 151 | $11K |
| 99442 | <1% | 343 | $10K | |
| 99177 | <1% | 2,073 | $10K | |
| 94010 | <1% | 315 | $7K | |
| 90480 | <1% | 158 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 589 | $6K |
| 0072A | <1% | 127 | $5K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 92 | $5K |
| 99460 | <1% | 99 | $4K | |
| 87070 | <1% | 100 | $4K | |
| 81025 | <1% | 736 | $4K | |
| 81002 | <1% | 1,687 | $4K | |
| 0071A | <1% | 85 | $3K | |
| 94664 | <1% | 223 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 163 | $2K |
| 80076 | <1% | 56 | $2K | |
| 99000 | <1% | 425 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $1K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 15 | $975.96 |
| 96380 | <1% | 46 | $964.78 | |
| 96161 | <1% | 222 | $877.32 | |
| 83655 | <1% | 49 | $824.82 | |
| 90686 | <1% | 1,624 | $767.54 | |
| 99441 | <1% | 38 | $565.44 | |
| 0003A | <1% | 13 | $538.81 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $478.67 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 12 | $353.84 |
| 86580 | <1% | 45 | $250.78 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 57 | $143.06 |
| 87807 | <1% | 12 | $124.56 | |
| 1036F | <1% | 732 | $122.50 | |
| 90670 | <1% | 164 | $77.00 | |
| 90672 | <1% | 40 | $19.00 | |
| 90647 | <1% | 39 | $17.00 | |
| 90723 | <1% | 14 | $7.00 | |
| 90734 | <1% | 14 | $6.50 | |
| 90633 | <1% | 12 | $5.50 | |
| 90656 | <1% | 78 | $1.20 | |
| 90661 | <1% | 15 | $0.11 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.